Author: Ershad Moradi

CQA

Critical Quality Attribute (CQA) in 2026: Expert Guide to Ensure Drug Quality

Critical Quality Attributes (CQAs) are crucial in pharmaceutical manufacturing because they directly affect drug safety, efficacy, and consistency. Regulatory agencies including the FDA and ICH require thorough CQA assessment to minimize risks and ensure high-quality medicines. By following best practices like early identification, risk assessment, and continuous monitoring, manufacturers can maintain robust production processes. Implementing modern strategies such as Quality by Design and integrating CQAs with quality assurance systems ensures compliance and safeguards patient health throughout the product lifecycle

Read More »

Out of Specification (OOS) in pharma Industry: Complete Investigation Guide & Prevention in 2026

Out of Specification (OOS) events represent a crucial quality challenge in pharmaceuticals, impacting product safety and regulatory compliance. Occurring in 2.3% of samples in 2026, these events demand thorough investigations and corrective actions. This blog explores the causes, investigation steps, and prevention strategies to help pharmaceutical companies strengthen their quality systems and maintain trust in their products.

Read More »
trend in pharma

Trending Analysis in Pharma Industry 2026: Complete Market Growth & Regulatory Insights

Trending analysis in the pharmaceutical industry highlights an average 12% annual growth in manufacturing capacity and a steady increase in FDA drug approvals. Quality assurance remains paramount, with the FDA conducting over 1,200 inspections each year to ensure product safety. Staying informed through authoritative sources like IQVIA, FDA, and WHO supports better decision-making in this rapidly evolving sector.

Read More »
Key Performance Indicators

Key Performance Indicator (KPI) Guide for Pharmaceutical Industry 2026 : Complete Quality Metrics

Approximately 30% of FDA Warning Letters cite inadequate monitoring of Key Performance Indicators (KPIs) as a major compliance issue, highlighting their crucial role in pharmaceutical operations. KPIs provide measurable data to track process efficiency, product quality, and regulatory adherence. Proper KPI management supports risk mitigation, enhances decision-making, and ensures patient safety.

Read More »
GMP and SOP

GMP SOPs Guide 2026: Master the Ultimate Compliance Framework for Pharma Excellence

Discover how mastering the GMP SOP framework drives pharmaceutical excellence. This guide explains why SOPs are living documents requiring ongoing updates, training, and reviews to maintain compliance and safeguard product quality. Learn key components, best practices, and global regulatory insights that empower pharma companies to excel in quality assurance and regulatory readiness.

Read More »